Atlas Trials

Effects of Tagatose on Glycemic Response and Gastrointestinal Microbiota in Healthy Adults

Clinical trial NCT06920641 · COMPLETED

Trial details

NCT number
NCT06920641
Sponsor
PepsiCo Global R&D
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Glucose IntoleranceMicrobial Colonization
Start date
2025-04-10
Primary completion
2026-01-19
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.